GlassScriptPhysician profile
Robert C Allen
NPI 1124091939
$3,020.03
in general payments reported to CMS, 2019-2025
37 companies · $86.45 in 2025
The $86.45 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $299 · 2021: $426 · 2022: $740 · 2023: $648 · 2024: $126 · 2025: $86.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484 · Travel and Lodging: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.59 |
| Travel and Lodging | $376.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $376.44 | 2023 | Da Vinci Surgical System |
| Astellas Pharma US INC | $261.55 | 2019-2022 | |
| Myovant Sciences INC. | $213.55 | 2021-2022 | |
| Boston Scientific Corporation | $179.37 | 2019-2024 | Ams 700, Lumenis Pulse 120h, Xpeeda Dsl Fiber |
| Teleflex LLC | $151.37 | 2021-2022 | |
| Edap Technomed INC | $142.88 | 2020 | |
| Myriad Genetic Laboratories, INC. | $139.15 | 2021-2024 | Prolaris |
| Medtronic, INC. | $135.55 | 2022-2023 | Interstim |
| Neotract INC. | $131.06 | 2019 | |
| Abbvie INC. | $119.60 | 2019-2023 | Lupron Depot |
| Bayer Healthcare Pharmaceuticals INC. | $112.58 | 2019-2023 | |
| Coloplast Corp | $89.57 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $88.10 | 2019-2020 | |
| Seagen INC. | $77.76 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $71.96 | 2023 | Provenge |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $59.38 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $52.82 | 2019-2020 | |
| Procept Biorobotics Corporation | $52.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $50.32 | 2019-2022 | |
| Cook Medical LLC | $48.86 | 2020 | |
| Accord Healthcare, INC. | $46.05 | 2022 | |
| 180 Medical, INC. | $45.12 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $40.62 | 2019-2022 | |
| Janssen Biotech, INC. | $39.22 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $37.72 | 2019-2022 | |
| Palette Life Sciences, INC. | $37.54 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $34.45 | 2025 | |
| Urovant Sciences INC | $34.02 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.97 | 2024 | Xarelto |
| Axonics, INC. | $22.01 | 2021 | |
| Sumitomo Pharma America, INC. | $21.55 | 2024 | Orgovyx |
| Hollister Incorporated | $15.72 | 2022 | |
| Abc Home Medical Supply, INC. | $15.61 | 2022 | |
| Laborie Medical Technologies Corp. | $14.70 | 2021 | |
| Pfizer INC. | $14.15 | 2019 | |
| Allergan, INC. | $12.00 | 2019 | |
| Srs Medical Systems, INC. | $11.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.